A trial begins in Washington involving Albertsons and claims tied to the state’s opioid crisis. According to the state, Albertsons and a pharmacist employed by the company failed to prevent opioid misuse, despite receiving warning signs. The state argues the retailer and its pharmacy operations helped contribute to the broader epidemic by not acting appropriately when potential misuse risk emerged. The lawsuit frames the dispute around whether the company’s practices complied with expectations for identifying and responding to red flags connected to controlled substances. Multiple reports describe the case as focusing on allegations that the company did not take sufficient steps to curb diversion or improper use of opioids. Albertsons and the pharmacist are expected to defend their conduct, and the case centers on the state’s contention that they should have intervened sooner based on the information available at the time. The proceedings will determine whether the state can establish liability for harms linked to alleged mishandling or insufficient safeguards in the context of opioid dispensing.